• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Aurobindo Pharma Limited — Updates, 27-12-2025: General Updates

    27-12-2025 | 11:58 am

    Aurobindo Pharma's subsidiary CuraTeQ terminated its agreement with BioFactura for the BFI-751 biosimilar. This strategic decision, driven by portfolio prioritization, is not expected to materially impact Aurobindo's overall biosimilars strategy.

    No comments yet. Be the first to comment!

    All announcements from Aurobindo Pharma Limited